Showing results (1081-1090 of 1,637) with videos related to

Sort By:
Pageof 164
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongationJ J Cook, G R Sitko, M A Holahan, et al.
Circulation|August 5, 1997
Nonpeptide glycoprotein IIb/IIIa inhibitors: 14: oral antithrombotic efficacy of L-738,167 in a conscious canine model of coronary artery electrolytic injuryJ J Cook, J D Glass, G R Sitko, et al.
Journal of Lipid Research|March 28, 2019
n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trialLara T Meital, Mark T Windsor, Rebecca M L Ramirez Jewell, et al.
The International Journal of Cardiovascular Imaging|January 7, 2014
Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRIKalie Y Kebed, Raed I Al Adham, Kalkidan Bishu, et al.
North Carolina Medical Journal|October 29, 2015
North Carolina College of Emergency Physicians' Guidance Document on Emergency Medical ServicesJames E Winslow, Antonio R Fernandez, Doug Swanson, et al.
Australian and New Zealand Journal of Public Health|August 16, 2016
Facilitating engagement through strong relationships between primary healthcare and Aboriginal and Torres Strait Islander peoplesCarol Davy, Alan Cass, John Brady, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
T2 Protect AD: Achieving a rapid recruitment timeline in a multisite clinical trial for individuals with mild to moderate Alzheimer's diseaseAladdin H Shadyab, Andrea Z LaCroix, Genevieve Matthews, et al.
Hypertension (Dallas, Tex. : 1979)|December 23, 2024
Effects of a Digital Intervention to Improve DASH and Blood Pressure Among US AdultsHailey N Miller, Sandy Askew, Miriam B Berger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1996
Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studiesT Prueksaritanont, L M Gorham, J D Ellis, et al.
Alzheimer'S Research & Therapy|May 2, 2025
Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's diseaseYuqi Qiu, Diane M Jacobs, Karen Messer, et al.
Pageof 164